Donegan Michael C

Interim CFO/CAO/VP of FinanceTherapeuticsMD, Inc. (TXMD) · full profile →Form 4 · filed Dec 9, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4K
Net Open-Market Flow
-$4K
Transactions
9
5 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 6, 2022Option exercise(M)262$05K
Dec 6, 2022Sell(S)910$4.78$4K5K
Dec 6, 2022Option exercise(M)534$05K
Dec 6, 2022Option exercise(M)380$05K
Dec 6, 2022Option exercise(M)2K$04K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 6, 2022Option exercise(M)262$0519
Dec 6, 2022Option exercise(M)534$01K
Dec 6, 2022Option exercise(M)380$0380
Dec 6, 2022Option exercise(M)2K$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-060585) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.